Atnaujinkite slapukų nuostatas

El. knyga: Pharmacoproteomics: Recent Trends and Applications

  • Formatas: EPUB+DRM
  • Išleidimo metai: 01-Sep-2024
  • Leidėjas: Springer International Publishing AG
  • Kalba: eng
  • ISBN-13: 9783031640216
  • Formatas: EPUB+DRM
  • Išleidimo metai: 01-Sep-2024
  • Leidėjas: Springer International Publishing AG
  • Kalba: eng
  • ISBN-13: 9783031640216

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

This book gives an overview of pharmacoproteomics and its clinical applications, as well as the latest information on drug mechanisms at the proteome level, the relationship between proteomics and toxicity or resistance, and how proteomics aid in discovery of new drug targets. The book also highlights recent advances in analytical methods, analysis, and interpretation of pharmacoproteomic data.

Pharmacoproteomics: Recent Trends and Applications is an ideal book for those working in pharmaceutical industries, as well as scientists, health care professionals, and researchers who work in the field of genomics, pharmacology, pharmacokinetics, toxicology, and pharmaceutical chemistry.


Overview of pharmacoproteomics and its clinical
applications.- Pharmacoproteomics and precision medicine.- Pharmacoproteomics
and drug target discovery.- Analytical methods in pharmacoproteomics.-
Bridging the gap between pharmacoproteomics and pharmacogenomics.- Analysis
and interpretation of pharmacoproteomic data.- Pharmacoproteomics and sickle
cell management.- Pharmacoproteomics and cancer
management.- Pharmacoproteomics and neurological disease
management.- Pharmacoproteomics and rheumatoid arthritis management.-
Proteomics and management of multiple sclerosis.- Biomarker development
against infections using proteomics.- Proteomics and COVID-19: recent
trends.- Proteomics in the pharmaceutical industry: prospects and
challenges.- Nanomaterials in proteomics.- Big data analytics in
pharmacoproteomics.- Recent mass spectrometry technologies in
pharmacoproteomics.- High throughput pre-clinical models and
pharmacoproteomics.
Prof. Seth K. Amponsah is the Head of the Department of Medical Pharmacology at the University of Ghana Medical School.





Prof. Kwabena F. M. Opuni is in the Department of Pharmaceutical Chemistry at the University of Ghana.





Prof. Yashwant V. Pathak is the Associate Dean for Faculty Affairs at the USF Health Taneja College of Pharmacy, University of South Florida.